NCT06969859

Brief Summary

This is a multi-centre, randomised, double-blind, placebo-controlled trial with two parallel groups in a 1:1 allocation to study the efficacy of Pulsed Electromagnetic Field Therapy (PEMF) in patients with mid-portion Achilles tendinopathy. All participants will be randomly divided into two groups: an intervention group (active PEMF and standard rehabilitation exercise) and a control group (sham PEMF and standard rehabilitation exercise). All self-reported, functional, and ultrasound findings will be evaluated by the investigator at baseline assessment, 1-month, 2-month, 3-month, 6-month and 12-month follow-up after initiating the intervention. The researcher will obtain written consent from all participants before the start of this study. All eligible participants will be informed about this study and given enough time to consider whether or not to participate; the clinician/research staff will answer all questions asked by the participants. The trial will be conducted in accordance with the Declaration of Helsinki and the ICH-GCP. Clinical research ethics approval for the trial will be obtained from the Joint Clinical Research Ethics Committee of The Chinese University of Hong Kong. All participants will be recruited from the clinics and centres of the participating institutions.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
20mo left

Started Oct 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress25%
Oct 2025Dec 2027

First Submitted

Initial submission to the registry

April 24, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

May 14, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

October 15, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

March 25, 2026

Status Verified

March 1, 2026

Enrollment Period

8 months

First QC Date

April 24, 2025

Last Update Submit

March 22, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Victorian Institute of Sports Assessment (VISA-A)

    The primary outcome measure will be the Victorian Institute of Sport Assessment (VISA-A) questionnaire, available in either the original English or validated Chinese version, depending on the participant's native language. This specific scoring system developed for the Achilles tendon is the most widely used score for clinical Achilles research. The VISA-A is scored on a scale of 0 to 100; lower scores indicate more severity of symptoms, while a score of 100 indicates a healthy and pain-free Achilles tendon.

    Baseline;2-month;3-month;6-month;12month follow-up after initiating the intervention

Secondary Outcomes (8)

  • Numeric Pain Rating Scale (NPRS)

    Baseline;2-month;3-month;6-month;12month follow-up after initiating the intervention

  • Foot and Ankle Outcome Scores (FAOS)

    Baseline;2-month;3-month;6-month;12month follow-up after initiating the intervention

  • Achilles tendon resting angle (ATRA)

    Baseline;2-month;3-month;6-month;12month follow-up after initiating the intervention

  • Tendon thickness

    Baseline;2-month;3-month;6-month;12month follow-up after initiating the intervention

  • Tendon cross sectional area

    Baseline;2-month;3-month;6-month;12month follow-up after initiating the intervention

  • +3 more secondary outcomes

Study Arms (2)

PEMF Therapy + Exercise

EXPERIMENTAL
Device: PEMFBehavioral: Alfredson eccentric training program

sham Therapy + Exercise

SHAM COMPARATOR
Behavioral: Alfredson eccentric training program

Interventions

PEMFDEVICE

The PEMF will be delivered using a BIXEPS device (Quantum Tx, Singapore) ; It is utilised by the patient placing the leg into the machine. This device is operated by participant individualized NFC cards, which will be centrally programmed to deliver either active PEMF (uniform 1mT, 50Hz) or sham PEMF (0mT, 0Hz) for 30 minutes. Because this biophysical intervention is non-invasive, and the electromagnetic fields emitted into the legs do not generate any sensation (e.g. heat, sound), participants will be blinded to the treatment. The protocol will be 180 minutes of PEMF therapy, performed in six 30-minute sessions 3 times a week and completed in 2 weeks.

PEMF Therapy + Exercise

All participants will be subject to a standardised rehabilitation exercise region consisting of stretching and eccentric exercises following the Alfredson protocol. The 12-week program will be taught by a physiotherapist or athletic trainer and supplemented by video tutorials. The regime begins with three 30-second static stretches for the gastrocnemius (knee extension) and soleus (knee flexion) muscles with 1-minute rest between each stretch. The 2nd part is eccentric exercises to the calves following the Alfredson protocol. This will be three sets of eccentric exercises lasting 12 weeks, with 15 sets twice a day. If participants are unable to complete three sets of 15 repetitions, they can start with fewer repetitions and sets (at least 2 sets of 10 repetitions each) and gradually increase to the total number of sets. Participants will perform the static stretching exercises from Step 1 at the end of each session

PEMF Therapy + Exercisesham Therapy + Exercise

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (\>18 years of age)
  • Clinical diagnosis of mid-Achilles tendinopathy
  • VISA-A score of \<60
  • Ultrasound evidence of Achilles tendinopathy (thickening \>7mm)

You may not qualify if:

  • Previous invasive treatment to the Achilles tendon (e.g. rupture repair, PRP injection etc)
  • Contraindication to PEMF (e.g. pregnancy, pacemakers)
  • Physical or psychological comorbidities impairing the ability to complete assessments (eg neurological deficits etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prince of Wales Hospital

Shatin, New Territories, 000000, Hong Kong

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor of Orthopaedics and Traumatology, CUHK Head of the Foot and Ankle Team / Honorary Associate Consultant, Prince of Wales Hospital Specialist in Orthopaedics and Traumatology, CUHK Medical Centre

Study Record Dates

First Submitted

April 24, 2025

First Posted

May 14, 2025

Study Start

October 15, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

March 25, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

only IPD used in the results publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
From 2028-5-31 to 2033-5-28

Locations